Becton wins $210 million contract with Novation:
This article was originally published in Clinica
Becton Dickinson has been awarded a $210 million contract with Novation for the supply of needles, syringes, safety needles and related products. The three-year agreement takes effect from January 1 2000 and includes two one-year renewal options. Novation, which is the supply company of VHA and the University HealthSystem Consortium, says the total value of sales to Becton could be higher as sales of safety products increase.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.